Skip to content

Shardul Amarchand Mangaldas & Co. Advises Omega Hospitals on its Acquisition of Cytecare Hospitals Private Limited

The deal marks Omega Hospitals’ entry into the Bengaluru oncology market and forms part of its nationwide expansion strategy. The transaction involved a full exit by Cytecare’s founding and major shareholders.

By
Content reader

Listen to this article

Ready to read this article aloud.
Shardul Amarchand Mangaldas & Co. Advises Omega Hospitals on its Acquisition of Cytecare Hospitals Private Limited

Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor to Hyderabad Institute of Oncology Private Limited (“HIOPL”), which operates the Omega Hospitals oncology network, in connection with its acquisition of a majority stake in Cytecare Hospitals Private Limited (“CHPL”), a Bengaluru-based cancer care provider.

This acquisition marks Omega Hospitals’ entry into the Bengaluru oncology market and forms part of its broader national expansion strategy to strengthen its presence across India.

The SAM transaction team was led by Nivedita Tiwari, Partner along with Devesh Pandey, Partner; Kuhuk Jain, Principal Associate; Tweisha Mishra, Senior Associate; and Anushka Ganguli, Associate.

WhatsApp LinkedIn

0 replies

Leave a Reply

Your email address will not be published. Required fields are marked *.

This site uses Akismet to reduce spam. Learn how your comment data is processed.